Rheonova is pleased to inform you that the research project BronchoClogDrain has received funding from the French National Research Agency (ANR). This project brings together various academic and private stakeholders focusing on obstructive lung diseases, specifically addressing the theme of mucus transport in the bronchi. In Chronic Obstructive Pulmonary Disease (COPD), the third leading cause of mortality worldwide, impaired clearance leads to severe lung obstruction, often requiring emergency hospitalization.
This ambitious 4-year program aims to understand the mechanisms of mucus transport in the bronchi by studying it in various forms, from in silico modeling to in vitro and in vivo experiments. The outcomes of this research will contribute to new therapeutic approaches, including the optimization of medical devices (Rheomuco, Simeox), to enhance patient care.
Rheonova is the coordinator of this project, which involves 7 partners : The company PHYSIO-ASSIST, the CINaM laboratories of CNRS and M2P2 of the University Côte d’Azur in Marseille, LJAD of the University Côte d’Azur in Nice, LRP of the University Grenoble Alpes, the Polytechnic Institute of Grenoble, and finally, the University Hospital Center (CHU) of Montpellier.